What is IBO (IBO) stock price today?

IBO (IBO) is currently trading at $0.43, down 2.27% today.

What is IBO P/E ratio?

IBO's P/E ratio is -1.61. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is IBO return on equity (ROE)?

IBO's return on equity (ROE) is -92.31%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is IBO's market cap?

IBO has a market capitalization of $5.38M.

AMEX · Biotechnology

IBO (IBO) Stock

$0.43 -2.27% AMEX: IBO Healthcare

Valuation

Metric	Value
Price	$0.43
Market Cap	$5.38M
P/E Ratio	-1.61
P/B Ratio	0.59
P/S Ratio	172.53
EPS (TTM)	$-0.38
52-Week High	$1.95
52-Week Low	$0.37
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-92.31%
ROA	-70.59%
ROCE	-26.67%
Gross Margin	-17.44%
Operating Margin	-117.82%
Net Margin	-329.69%
Debt/Equity	0.00
Current Ratio	0.22

Annual Financials (USD)

Metric	2024	2025
Revenue	$2.0M	$0
Operating Profit	$1.0M	$-4.0M
Net Profit	$-2.0M	$-12.0M
EPS	$-0.01	$-0.38
Op Margin	23.7%	-13343.8%

Balance Sheet (USD)

Metric	2024	2025
Total Assets	$20.0M	$17.0M
Total Liabilities	$13.0M	$2.0M
Cash	$2.0M	$0
Borrowings	$9.0M	$0

Cash Flow (USD)

Metric	2024	2025
Operating Cash Flow	$-6.0M	$-2.0M
Investing Cash Flow	$0	$0
Financing Cash Flow	$0	$0
Net Cash Flow	$3.0M	$-2.0M
Free Cash Flow	$-6.0M	$-2.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-24.85%
Quick Ratio	0.19
Interest Coverage	-4.00
Return 1Y	-31.34%
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held89.02%

Institutions Held3.45%

Institutions Float Held31.44%

Institutional Holder	Shares	Report Date
Geode Capital Management, LLC	1,192,925	2026-03-31
Vanguard Capital Management LLC	708,168	2026-03-31
State Street Corporation	607,897	2026-03-31
Vanguard Fiduciary Trust Co	585,198	2026-03-31
Blackrock Inc.	259,946	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ADIL	$3.33	+1.22%	-1.14	$3.20M	0.00%
AIM	$0.24	-5.84%	-0.09	$801193	0.00%
BCLIBrainstorm Cell Therapeutics Inc.	$0.98	+6.52%	-1.04	$10.81M	0.00%
CYCN	$3.57	+0.28%	-2.99	$16.71M	0.00%
MLECMoolec Science S.A.	$7.37	+2.43%	-0.03	$5.35M	0.00%

About IBO

IBO is led by CEO Frank D. Heuszel, publicly traded since 2024.

IBO stock trades at $0.43 with a market capitalization of $5.38M. The stock is valued at a price-to-earnings (P/E) ratio of -1.61, price-to-book of 0.59, price-to-sales of 172.53. Over the past 52 weeks the stock has ranged between $0.37 and $1.95, and currently trades 77.9% below its 52-week high.

On profitability, IBO generates a return on equity (ROE) of -92.31%, return on capital employed of -26.67%, an operating margin of -117.82%, a net profit margin of -329.69%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides